Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Other Working Capital Changes: 2010-2025

Historic Other Working Capital Changes for China Pharma Holdings (CPHI) over the last 15 years, with Sep 2025 value amounting to $178.

  • China Pharma Holdings' Other Working Capital Changes rose 105.34% to $178 in Q3 2025 from the same period last year, while for Sep 2025 it was $64,401, marking a year-over-year increase of 180.37%. This contributed to the annual value of $73,716 for FY2024, which is 117.42% up from last year.
  • China Pharma Holdings' Other Working Capital Changes amounted to $178 in Q3 2025, which was down 99.57% from $41,246 recorded in Q2 2025.
  • China Pharma Holdings' 5-year Other Working Capital Changes high stood at $452,021 for Q4 2022, and its period low was -$392,021 during Q1 2023.
  • For the 3-year period, China Pharma Holdings' Other Working Capital Changes averaged around -$32,376, with its median value being -$3,333 (2024).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 1,028.42% in 2021, then soared by 342.39% in 2023.
  • China Pharma Holdings' Other Working Capital Changes (Quarterly) stood at -$215,627 in 2021, then skyrocketed by 309.63% to $452,021 in 2022, then plummeted by 118.33% to -$82,849 in 2023, then spiked by 185.69% to $70,996 in 2024, then soared by 105.34% to $178 in 2025.
  • Its Other Working Capital Changes stands at $178 for Q3 2025, versus $41,246 for Q2 2025 and -$48,019 for Q1 2025.